Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content
© Freepik

The team has developed state-of-the art risk stratification methods for Alzheimer’s disease using advanced analytical techniques such as polygenic risk scores. They are preparing exemplar analyses to test the utility of the Data Portal for cross-cohort analyses, linking genetic, population and routinely-collected health records.